Healthy Living Europe
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Europe

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on June 23, 2025

PositiveSingles lanza su plataforma en español para citas y apoyo entre personas con ITS

PositiveSingles lanza su plataforma en español para citas y apoyo entre personas con ITS

La versión localizada tiene como objetivo apoyar a la comunidad hispanohablante global afectada por infecciones de transmisión sexual (ITS). CIUDAD DE MéXICO, CIUDAD DE MéXICO, MEXICO, June 23, 2025 /⁨EINPresswire.com⁩/ -- PositiveSingles, la comunidad en …

Biomed Industries Presents Breakthrough Phase 2 Results of NA-931,  an Oral Quadruple Agonist for Obesity , at ADA 2025

Biomed Industries Presents Breakthrough Phase 2 Results of NA-931, an Oral Quadruple Agonist for Obesity , at ADA 2025

Biomed Industries, Inc. Presents Breakthrough Phase 2 Results of NA-931, a First-in-Class Oral Quadruple Agonist for the Treatment of Obesity , at ADA 2025 SAN JOSE, CA, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- Biomed Industries, Inc. ( …

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of …

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series

SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management …

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to…

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to…

PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …

Jushi and Real Housewives Star Stacey Rusch Celebrate Successful Launch of Lifestyle Cannabis Brand ‘Shayo’

Jushi and Real Housewives Star Stacey Rusch Celebrate Successful Launch of Lifestyle Cannabis Brand ‘Shayo’

(Photo credit: Andreas Neumann) BOCA RATON, Fla., June 23, 2025 (GLOBE NEWSWIRE) --  Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) has partnered with entrepreneur, philanthropist, and Real Housewives of Potomac star Stacey Rusch …

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)

LOUISVILLE, Ky., June 23, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera Pharmaceuticals, LLC for ROMVIMZA™ (vimseltinib), which has been approved by …

Global Dental CAD/CAM Market: Analyzing the Latest Trends and Advancements in the Industry During 2023-2032

Global Dental CAD/CAM Market: Analyzing the Latest Trends and Advancements in the Industry During 2023-2032

PORTLAND, HI, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research recently published a report on the dental CAD/CAM market, which highlights that the industry accounted for $3.4 billion in 2022 and is anticipated to gather a sum of …

Cidara Announces Proposed Public Offering of Common Stock

Cidara Announces Proposed Public Offering of Common Stock

SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an …

Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank

Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank

CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in September 2024 Phase 2 FALCON clinical trial of TERN-601 completed enrollment; 12-week data expected in 4Q 2025 FOSTER CITY, Calif., June …

The Transdermal Drug Delivery Systems Market Report 2025 – Strategic Insights for Companies Seeking Growth & Advantage

The Transdermal Drug Delivery Systems Market Report 2025 – Strategic Insights for Companies Seeking Growth & Advantage

The Business Research Company’s Transdermal Drug Delivery Systems Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Tuberous Sclerosis Drug Market Forecast to 2034 – For Business Leaders, Analysts, and Strategic Teams

Tuberous Sclerosis Drug Market Forecast to 2034 – For Business Leaders, Analysts, and Strategic Teams

The Business Research Company’s Tuberous Sclerosis Drug Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest …

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative …

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …

iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing

iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing

Study indicates iMDx flagship technology’s equivalence with commercially available dd-cfDNA test kits Head-to-head comparison of iMDx’s digital PCR-based test kits with NGS kits shows consistent results in 96 transplant patients Data was presented at the …

Stage4Hope™ Launches to Transform the Advanced-Stage Cancer Experience

Stage4Hope™ Launches to Transform the Advanced-Stage Cancer Experience

ATLANTA, June 23, 2025 (GLOBE NEWSWIRE) -- Stage4Hope™, a 501(c)(3) public charity, officially launches this month with a powerful mission: to improve the lives of individuals diagnosed with advanced-stage cancer by accelerating access to world-class …

Integrated Recirculating Aquaculture System RAS Global Market Assessments Predict, Poised to Reach $7.24 Billion by 2029

Integrated Recirculating Aquaculture System RAS Global Market Assessments Predict, Poised to Reach $7.24 Billion by 2029

The Business Research Company’s Integrated Recirculating Aquaculture System RAS Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /⁨EINPresswire.com⁩/ -- What Is The Growth …

Global Hypochlorous Acid Market Set For 8.4% Growth, Reaching $8.11 Billion By 2029

Global Hypochlorous Acid Market Set For 8.4% Growth, Reaching $8.11 Billion By 2029

The Business Research Company’s Hypochlorous Acid Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 23, 2025 /⁨EINPresswire.com⁩/ -- Is The Market For Hypochlorous Acid Strong And Growing? …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service